1. Home
  2. Analysis

Thyroid cancer and drugs of ingredients of risankizumab-rzaa (a real world drug study)


Summary:

Thyroid cancer is found among people who take drugs with ingredients of risankizumab-rzaa, especially for people who are female, 50-59 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 46,011 people who have side effects when taking drugs with ingredients of risankizumab-rzaa from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Skyrizi.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 03, 2026

46,011 people reported to have side effects when taking drugs with ingredients of risankizumab-rzaa.
Among them, 37 people (0.08%) have Thyroid cancer

What is Thyroid cancer?

Thyroid cancer is found to be associated with 587 drugs and 844 conditions by eHealthMe. Check the latest studies of Thyroid cancer.

Number of reports submitted per year:

Could drugs with ingredients of risankizumab-rzaa cause Thyroid cancer?

Time on drugs with ingredients of risankizumab-rzaa when people have Thyroid cancer *:

  • < 1 month: 50.0 %
  • 1 - 6 months: 33.33 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 16.67 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Thyroid cancer when taking drugs with ingredients of risankizumab-rzaa *:

  • female: 67.57 %
  • male: 32.43 %

Age of people who have Thyroid cancer when taking drugs with ingredients of risankizumab-rzaa *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 9.09 %
  • 30-39: 0.0 %
  • 40-49: 27.27 %
  • 50-59: 36.36 %
  • 60+: 27.27 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Psoriasis (immune-mediated disease that affects the skin): 34 people, 91.89%
  2. High Blood Pressure: 3 people, 8.11%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.41%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 5.41%
  5. High Blood Cholesterol: 2 people, 5.41%
  6. Thyroid Diseases: 1 person, 2.70%
  7. Pain: 1 person, 2.70%
  8. Heart Disease: 1 person, 2.70%
  9. Diabetes: 1 person, 2.70%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Otezla: 2 people, 5.41%
  2. Humira: 2 people, 5.41%
  3. Clopidogrel: 2 people, 5.41%
  4. Amlodipine: 2 people, 5.41%
  5. Tylenol: 1 person, 2.70%
  6. Tremfya: 1 person, 2.70%
  7. Synthroid: 1 person, 2.70%
  8. Metformin: 1 person, 2.70%
  9. Levothyroxine Sodium: 1 person, 2.70%

Other side effects people have besides Thyroid cancer *:

You may use this to check any potential undetected side effects.

  1. Psoriasis (immune-mediated disease that affects the skin): 6 people, 16.22%
  2. Stress And Anxiety: 3 people, 8.11%
  3. Urinary Bladder Haemorrhage (urinary bladder bleeding): 2 people, 5.41%
  4. Seasonal Allergy (allergic condition due to certain season): 2 people, 5.41%
  5. Cyst (a closed sac): 2 people, 5.41%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.41%
  7. Intracranial Aneurysm (bulging, weak area in the wall of a cranial artery): 2 people, 5.41%
  8. Memory Loss: 2 people, 5.41%
  9. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 5.41%
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of risankizumab-rzaa, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on risankizumab-rzaa. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.